Premium
P3‐451: SUVN‐502: A potent and selective 5‐HT6 antagonist, potential drug for the treatment of Alzheimer's disease
Author(s) -
Nirogi Ramakrishna,
Kandikere Vishwottam,
Mudigonda Koteshwara,
Bhyrapuneni Gopinadh,
Shinde Anil,
Kambhampati Ramasastri,
Jayarajan Pradeep,
Abraham Renny,
Mulla Mohamad Sadik,
Muddageswararao,
Benade Vijay,
Saralaya Ramanatha
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.1895
Subject(s) - donepezil , tolerability , serotonergic , dementia , pharmacology , adverse effect , medicine , memantine , morris water navigation task , neurotransmitter , glutamatergic , neuropharmacology , neuroscience , psychology , glutamate receptor , disease , serotonin , receptor , hippocampus